but more recent evidence has highlighted the role of the cerebellum. Here we review evidence 28 from neuroimaging and non-invasive brain stimulation that demonstrate altered cerebellar 29 activity in PD may be both a pathophysiological and compensatory mechanism depending on 30 dopaminergic medication and symptoms.
31
Parkinson's disease (PD) is the second most common neurodegenerative disorder. It is 33 associated with a wide range of cognitive and motor impairments, including bradykinesia, 34 rigidity, resting tremor, and postural instability (Jankovic, 2008) . PD is thought to arise from or a compensatory mechanism to overcome dysfunction in the striato-thalamo-cortical circuitry. enhanced connectivity between the dentate nucleus and cerebellum compared to healthy controls.
64
This study and most others have scanned PD patients in the OFF state, or in the drug-naïve state, effects on behavior, and that the cerebellum may be either compensatory or pathological in PD.
104
One complexity to this interpretation relates to the heterogeneity of PD symptoms. PD can be 105 broken down into two main subtypes: tremor dominant and akinetic-rigid (Wu & Hallett, 2013) . The lack of an effect of cTBS on STDT in PD patients ON medication may relate to the 141 state-dependent nature of TBS, such that the state of the underlying brain activity during 142 stimulation influences the direction and magnitude of the after effect of TBS (Hallett, 2007) . Therefore, it is unclear whether these results can be generalized to patients ON medication. 
